Scientists summarizes the critical mediators and mechanisms involved in immune cell trafficking in IBD and the available evidence for efficacy, safety and pharmacokinetics of sphingosine 1-phosphate receptor modulators in IBD and other immune-mediated disorders.
[Nature Reviews Gastroenterology & Hepatology]
Sorry, but the selected Zotpress account can't be found.
